The patented ADT Rendering process relies on the hydrolysis or breaking down of the complex organic compounds, particularly protein to small elementary units. For most living organisms the application of heat alone will denature or alter the shape of the functional organic components including the protein causing inactivation of these organisms. However the infective agent of TSEs is not really a living organism but rather small pieces of individual rogue prion protein, identical in chemical composition but of a different shape to a naturally occurring protein, and these prions are incredibly resistant to heat, requiring temperatures in excess of 850°C to inactivate them. Hence the advantage of chemical de-activation of TSE’s at temperatures below 100°C is such an exciting breakthrough.
The simple theory of the biochemical application of the ADT process is that the treatment of the raw material will allow all protein including the rogue prion protein to be hydrolysed or broken down to small units or polypeptides thus retaining its nutritional value but totally clear of any pathological infectivity.